Skip to search formSkip to main contentSkip to account menu

ABI 1648

Known as: ABI-1648, ABI1648 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

KRM 1648

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Determination of rifalazil in dog plasma by liquid-liquid extraction and LC-MS/MS: quality assessment by incurred sample analysis.
2007
2007
Determination of rifalazil, a potent antibacterial agent, in human plasma by liquid-liquid extraction and LC-MS/MS.
2003
2003
In Vitro Activities of Rifamycin Derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae
ABSTRACT ABI-1648 (rifalazil) is a semisynthetic rifamycin with potent bactericidal activity against intracellular respiratory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)